Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer | |
Ji, Shangwei; Sun, Yu; Liu, Lin; Lie, Chunsheng; Jig, Hong | |
刊名 | JOURNAL OF BUON
![]() |
2019 | |
卷号 | 24期号:4 |
关键词 | hepatocellular carcinoma transcatheter arterial chemoembolization radiofrequency ablation prognosis |
ISSN号 | 1107-0625 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3511533 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Ji, Shangwei,Sun, Yu,Liu, Lin,et al. Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer[J]. JOURNAL OF BUON,2019,24(4). |
APA | Ji, Shangwei,Sun, Yu,Liu, Lin,Lie, Chunsheng,&Jig, Hong.(2019).Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer.JOURNAL OF BUON,24(4). |
MLA | Ji, Shangwei,et al."Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer".JOURNAL OF BUON 24.4(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论